| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
|
|
|
|||||||
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
E-mail contact: kondrar{at}ccf.org, antochm{at}ccf.org
The basic helix–loop–helix (bHLH) –PAS domain containing transcription factors CLOCK and BMAL1 are two major components of the circadian molecular oscillator. It is known that the CLOCK/BMAL1 complex positively regulates the activity of E-box containing promoters. Here we demonstrate that the CLOCK/BMAL1 complex can also suppress the activity of some promoters upon its interaction with CRYPTOCHROME (CRY). Such a dual function of the circadian transcriptional complex provides a mechanistic explanation for the unpredicted pattern of circadian gene expression in the tissues of Bmal1 null mice. We speculate that the switch from transcriptional activation to transcriptional repression may provide a highly efficient mechanism for circadian control of gene expression. We also show that CLOCK/BMAL1 can interfere with promoter regulation by other, non-circadian, transcription factors including N-MYC and ETS, leading to attenuation or abrogation of transcription of CLOCK/BMAL1-controlled stress-induced genes. We propose that, based upon these results, both circadian repression and activation of the transcription of different target genes are required for circadian responses to various external stimuli, including genotoxic stress induced by anticancer treatment.
Key words: transcriptional activation • stress response
This article has been cited by other articles:
|
|
 |
|
  K. A. Lamia, K.-F. Storch, and C. J. Weitz From the Cover: Physiological significance of a peripheral tissue circadian clock PNAS, September 30, 2008; 105(39): 15172 - 15177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Lemos, L. Goodspeed, L. Tonelli, M. P. Antoch, S. R. Ojeda, and H. F. Urbanski Evidence for Circadian Regulation of Activating Transcription Factor 5 But Not Tyrosine Hydroxylase by the Chromaffin Cell Clock Endocrinology, December 1, 2007; 148(12): 5811 - 5821. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Krugluger, A. Brandstaetter, E. Kallay, J. Schueller, E. Krexner, S. Kriwanek, E. Bonner, and H. S. Cross Regulation of Genes of the Circadian Clock in Human Colon Cancer: Reduced Period-1 and Dihydropyrimidine Dehydrogenase Transcription Correlates in High-Grade Tumors Cancer Res., August 15, 2007; 67(16): 7917 - 7922. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. H. Miller, E. L. McDearmon, S. Panda, K. R. Hayes, J. Zhang, J. L. Andrews, M. P. Antoch, J. R. Walker, K. A. Esser, J. B. Hogenesch, et al. Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation PNAS, February 27, 2007; 104(9): 3342 - 3347. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Taniguchi, M. Katayama, R. Ito, N. Takai, T. Kondo, and T. Oyama labA: a novel gene required for negative feedback regulation of the cyanobacterial circadian clock protein KaiC Genes & Dev., January 1, 2007; 21(1): 60 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. V. Kondratov, A. A. Kondratova, V. Y. Gorbacheva, O. V. Vykhovanets, and M. P. Antoch Early aging and age-related pathologies in mice deficient in BMAL1, the core componentof the circadian clock Genes & Dev., July 15, 2006; 20(14): 1868 - 1873. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
